A novel artificial intelligence (AI) tool has revealed how disease-linked proteins misfold into harmful structures, a key ...

In connection with our new strategy, we also announced today that Spruce has acquired Tralesinidase Alfa Enzyme Replacement Therapy or TA-ERT for the treatment of MPS IIIB. We we anticipate making a ...